Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01100658 · OUTCOME

Effectiveness of Methylphenidate on Neurocognitive Components

Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors · Source last updated 2015-03-27

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
Not reported
Unit
Not reported
Interval / dispersion
Not reported
Time frame
Week 1 and Week 2

What was measured

Child performance on neuropsychological testing (i.e., using Test of Variables of Attention \[TOVA\] which is a computerized test of attention that assists in the screening, diagnosis, and treatment monitoring of attention disorders, like Attention Deficit Hyperactivity Disorder \[ADHD\], and working memory index of the WisSC IV. Standard scores average = 100 +/- 15. Higher scores indicate better performance. Scores \< or = 1 SD below the mean represent area of deficit.

Analysis population: No patients received treatment, therefore analysis was not done.

Groups in this outcome

Participant With Attention Deficit

Participant previously had acute lymphoblastic leukemia or brain tumor to be treated with Methylphenidate or Placebo - Administered 1 capsule each day for 1 week, .3 mg/kg dose.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Participant With Attention Deficit0

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields
anticipated Posting Date
2011-07
denoms
  1. counts
    1. group Id
      OG000
      value
      0
    units
    Participants
description
Child performance on neuropsychological testing (i.e., using Test of Variables of Attention \[TOVA\] which is a computerized test of attention that assists in the screening, diagnosis, and treatment monitoring of attention disorders, like Attention Deficit Hyperactivity Disorder \[ADHD\], and working memory index of the WisSC IV. Standard scores average = 100 +/- 15. Higher scores indicate better performance. Scores \< or = 1 SD below the mean represent area of deficit.
groups
  1. description
    Participant previously had acute lymphoblastic leukemia or brain tumor to be treated with Methylphenidate or Placebo - Administered 1 capsule each day for 1 week, .3 mg/kg dose.
    id
    OG000
    title
    Participant With Attention Deficit
population Description
No patients received treatment, therefore analysis was not done.
reporting Status
POSTED
time Frame
Week 1 and Week 2
title
Effectiveness of Methylphenidate on Neurocognitive Components
type
PRIMARY

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice